Ambu has replaced its duodenoscopes the world over: "We have the product of choice"
Following a clinical study with 29 people, medtech company Ambu has already replaced its duodenoscopes on the global market. The company's CEO, Juan Jose Gonzalez, is sure the new version will beat competitors and become the preferred choice.
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN
In connection with Ambu's newly released full-year financial report, the company has announced updating its duodenoscopes to a new version called Ascope Duodeno 1.5 for use in duodenoscopy procedures. Ambu CEO Juan Jose Gonazalez confirms to MedWatch that the product transition was initiated before the announcement.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
